News

Active in over 90 countries, we are now proud to announce that we are joining forces with GlobeMed  Lebanon. Hence, we can ensure that all patients…

At the prestigious Step Award in Frankfurt on December the 2^nd, CENTOGENE succeeded in two categories. In the areas of Finance as well as…

Centogene is pleased to announce one beneficiary of its Rare Disease Day Quiz 2014. The Regroupement québécois des maladies orphelines (RQMO)/Quebec…

Centogene announces the transfer of its Canadian business to LifeLabs Medical Laboratory Services ("LifeLabs"), the largest laboratory throughout…

Gain more insight into genetic testing and its medical benefit: Radio interview by Prof Arndt Rolfs, MD, Chief Medical Director

Centogene is committed to providing the highest level of quality. A part of that commitment is participating in multiple Proficiency Testing Schemes…

CENTOGENE is pleased to announce the start of its operations in India through its subsidiary, Centogene India Private Limited. Physicians and patients…

Genetic testing is sometimes hampered by transportation problems and storage of patient samples. In an effort to make testing easier and more…

Objective: While several genes have been identified to cause Parkinson's disease (PD), monogenic forms explain only a small proportion of cases. We…

Centogene Holding AG (formerly Arcensus AG), parent company of a group of diagnostic laboratories, announced today that Michael Schlenk, former CEO of…